Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM; Mycotic Ulcer Treatment Trial Group. Sun CQ, et al. Among authors: ray kj. Ophthalmology. 2014 Aug;121(8):1495-500.e1. doi: 10.1016/j.ophtha.2014.03.004. Epub 2014 Apr 16. Ophthalmology. 2014. PMID: 24746358 Free PMC article. Clinical Trial.
The steroids for corneal ulcers trial: study design and baseline characteristics.
Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group. Srinivasan M, et al. Among authors: ray kj. Arch Ophthalmol. 2012 Feb;130(2):151-7. doi: 10.1001/archophthalmol.2011.303. Epub 2011 Oct 10. Arch Ophthalmol. 2012. PMID: 21987581 Free PMC article. Clinical Trial.
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group. Srinivasan M, et al. Among authors: ray kj. Arch Ophthalmol. 2012 Feb;130(2):143-50. doi: 10.1001/archophthalmol.2011.315. Epub 2011 Oct 10. Arch Ophthalmol. 2012. PMID: 21987582 Free PMC article. Clinical Trial.
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Sy A, et al. Among authors: ray kj. Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):267-72. doi: 10.1167/iovs.11-7840. Invest Ophthalmol Vis Sci. 2012. PMID: 22159005 Free PMC article. Clinical Trial.
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.
Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Cevallos V, Oldenburg CE, Ray KJ, Toutain-Kidd CM, Glidden DV, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Lalitha P, et al. Among authors: ray kj. Clin Infect Dis. 2012 May;54(10):1381-7. doi: 10.1093/cid/cis189. Epub 2012 Mar 23. Clin Infect Dis. 2012. PMID: 22447793 Free PMC article.
Differentiation of etiologic agents of bacterial keratitis from presentation characteristics.
Mascarenhas J, Srinivasan M, Chen M, Rajaraman R, Ravindran M, Lalitha P, Oldenburg CE, Ray KJ, Glidden DV, Costanza S, Lietman TM, Acharya NR. Mascarenhas J, et al. Among authors: ray kj. Int Ophthalmol. 2012 Dec;32(6):531-8. doi: 10.1007/s10792-012-9601-x. Epub 2012 Jun 30. Int Ophthalmol. 2012. PMID: 22752605 Free PMC article. Clinical Trial.
Nocardia keratitis: clinical course and effect of corticosteroids.
Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Lalitha P, et al. Among authors: ray kj. Am J Ophthalmol. 2012 Dec;154(6):934-939.e1. doi: 10.1016/j.ajo.2012.06.001. Epub 2012 Sep 5. Am J Ophthalmol. 2012. PMID: 22959881 Free PMC article. Clinical Trial.
Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.
Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM. Oldenburg CE, et al. Among authors: ray kj. Invest Ophthalmol Vis Sci. 2013 Feb 28;54(2):1522-6. doi: 10.1167/iovs.12-11246. Invest Ophthalmol Vis Sci. 2013. PMID: 23385795 Free PMC article. Clinical Trial.
Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
Oldenburg CE, Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Borkar DS, Ray KJ, Zegans ME, McLeod SD, Porco TC, Lietman TM, Acharya NR. Oldenburg CE, et al. Among authors: ray kj. Ophthalmic Epidemiol. 2013 Jun;20(3):155-8. doi: 10.3109/09286586.2013.790978. Epub 2013 May 10. Ophthalmic Epidemiol. 2013. PMID: 23662986 Free PMC article. Clinical Trial.
82 results